
Aprea Therapeutics, Inc.
APREHealthcare|Biotechnology|US
$0.52
+0.02 (+4.50%)
DCF Value
$2.14
Tangible Book / Share
$0.64
Cash / Share
$0.71
Ownership Breakdown
91.0%
Float
12.6M
Shares Outstanding
11.5M
Float Shares
Major Holders (26)
Combined: 204.9%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Soleus GP, LLC | Other | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Capital Master Fund, L.P. | Non-US institution | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Private Equity Fund III, L.P. | Partnership | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus PE GP III, LLC | Other | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Private Equity GP III, LLC | Other | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Capital, LLC | Other | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Capital Group, LLC | Other | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Guy Levy | Individual | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Soleus Capital Management, L.P. | Partnership | 9.99% | 1,271,080 | Apr 1, 2026 | 13D/G |
| Ryan Wilder | HC, IN | 9.90% | 22,654,832 | May 15, 2026 | 13D/G |
| Vestal Point Capital, LP | IA, PN | 9.90% | 22,654,832 | May 15, 2026 | 13D/G |
| AIGH Capital Management LLC | IA, OO | 9.90% | 1,186,294 | Apr 27, 2026 | 13D/G |
| Orin Hirschman | HC, IN | 9.90% | 1,186,294 | Apr 27, 2026 | 13D/G |
| Matthew Sesterhenn | HC, IN | 9.90% | 1,271,081 | Apr 7, 2026 | 13D/G |
| Squadron Master Fund LP | Partnership | 9.90% | 1,271,081 | Apr 7, 2026 | 13D/G |
| Squadron Capital Management LLC | IA, HC | 9.90% | 1,271,081 | Apr 7, 2026 | 13D/G |
| William Blank | HC, IN | 9.90% | 1,271,081 | Apr 7, 2026 | 13D/G |
| Wilmot B. Harkey | Holding company | 4.50% | 411,520 | Feb 13, 2026 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 4.50% | 411,520 | Feb 13, 2026 | 13D/G |
| Daniel Mack | Holding company | 4.50% | 411,520 | Feb 13, 2026 | 13D/G |
| Stonepine Capital Management, LLC | IA, OO | 4.30% | 239,416 | May 14, 2025 | 13D/G |
| Jon M. Plexico | HC, IN | 4.30% | 239,416 | May 14, 2025 | 13D/G |
| Stonepine GP, LLC | Other | 4.30% | 239,416 | May 14, 2025 | 13D/G |
| Stonepine Capital, L.P. | Partnership | 4.30% | 239,416 | May 14, 2025 | 13D/G |
| Lytton Laurence W | Individual | 3.20% | 390,807 | Aug 13, 2026 | 13D/G |
| Sio Capital Management, LLC | Investment adviser | 1.93% | 112,223 | Nov 12, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 797,432 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Grissinger Michael | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Grissinger Michael | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Gruia Gabriela | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Gruia Gabriela | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Peters Richard | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Peters Richard | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| BIZZARI JEAN-PIERRE | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| BIZZARI JEAN-PIERRE | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Duey Marc | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Duey Marc | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Pamukcu Rifat | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Pamukcu Rifat | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Seizinger Bernd R. | director | Jun 16, 2026 | AWARD | 3,135 | — | — | Form 4 |
| Seizinger Bernd R. | director | Jun 16, 2026 | AWARD | 12,555 | $0.73 | $9.2K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 31, 2026 | BUY | 30,978 | $0.00 | $30.98 | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 31, 2026 | BUY | 30,978 | $0.68 | $21.2K | Form 4 |
| Peters Richard | director | Mar 31, 2026 | BUY | 123,915 | $0.00 | $123.92 | Form 4 |
| Peters Richard | director | Mar 31, 2026 | BUY | 123,915 | $0.68 | $84.6K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Mar 12, 2026 | AWARD | 20,175 | — | — | Form 4 |
| Gilad Oren | director, officer: President/CEO | Mar 12, 2026 | AWARD | 80,700 | $0.77 | $61.7K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 12, 2026 | AWARD | 10,095 | — | — | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 12, 2026 | AWARD | 40,380 | $0.77 | $30.9K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Jan 30, 2026 | BUY | 28,100 | $0.89 | $25.0K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Jan 30, 2026 | BUY | 28,100 | $0.77 | $21.5K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Jan 30, 2026 | BUY | 5,700 | $0.89 | $5.1K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Jan 30, 2026 | BUY | 5,700 | $0.77 | $4.4K | Form 4 |
| Duey Marc | director | Dec 10, 2025 | BUY | 21,459 | $1.17 | $25.0K | Form 4 |
| Duey Marc | director | Dec 10, 2025 | BUY | 21,459 | $1.04 | $22.3K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Dec 10, 2025 | BUY | 5,000 | $1.17 | $5.8K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Dec 10, 2025 | BUY | 5,000 | $1.04 | $5.2K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Dec 10, 2025 | BUY | 21,459 | $0.00 | $2.15 | Form 4 |
| Gilad Oren | director, officer: President/CEO | Dec 10, 2025 | BUY | 21,459 | $1.04 | $22.3K | Form 4 |
| Seizinger Bernd R. | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Seizinger Bernd R. | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| Peters Richard | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| Peters Richard | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Pamukcu Rifat | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Pamukcu Rifat | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| HENNEMAN JOHN B III | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| Gruia Gabriela | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| Gruia Gabriela | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Grissinger Michael | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| Grissinger Michael | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Duey Marc | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Duey Marc | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| BIZZARI JEAN-PIERRE | director | Jun 5, 2025 | AWARD | 4,185 | $1.81 | $7.6K | Form 4 |
| BIZZARI JEAN-PIERRE | director | Jun 5, 2025 | AWARD | 1,045 | — | — | Form 4 |
| Gilad Oren | director, officer: President/CEO | Apr 3, 2025 | BUY | 2,497 | $1.80 | $4.5K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Apr 3, 2025 | BUY | 3,003 | $1.87 | $5.6K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 27, 2025 | AWARD | 3,365 | — | — | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 27, 2025 | AWARD | 13,460 | $2.20 | $29.6K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Mar 27, 2025 | AWARD | 6,725 | — | — | Form 4 |
| Gilad Oren | director, officer: President/CEO | Mar 27, 2025 | AWARD | 26,900 | $2.20 | $59.2K | Form 4 |
| Duey Marc | director | Oct 18, 2024 | SELL | 6,462 | $4.58 | $29.6K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Oct 23, 2024 | BUY | 500 | $3.92 | $2.0K | Form 4 |
| Duey Marc | director | Oct 16, 2024 | BUY | 30,000 | $4.39 | $131.7K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Oct 15, 2024 | BUY | 250 | $2.90 | $725.00 | Form 4 |
| Duey Marc | director | Oct 14, 2024 | BUY | 190 | $2.58 | $490.20 | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Oct 11, 2024 | BUY | 50 | $2.46 | $123.19 | Form 4 |
| Seizinger Bernd R. | director | Oct 11, 2024 | BUY | 10,000 | $2.68 | $26.8K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Oct 14, 2024 | BUY | 1,000 | $2.59 | $2.6K | Form 4 |
| Gilad Oren | director, officer: President/CEO | Oct 10, 2024 | BUY | 150 | $2.54 | $381.00 | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Oct 10, 2024 | BUY | 450 | $2.61 | $1.2K | Form 4 |
| Seizinger Bernd R. | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| Seizinger Bernd R. | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Pamukcu Rifat | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| Pamukcu Rifat | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Peters Richard | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Peters Richard | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Grissinger Michael | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Grissinger Michael | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| Duey Marc | director | Jun 20, 2024 | AWARD | 1,045 | — | — | Form 4 |
| Duey Marc | director | Jun 20, 2024 | AWARD | 4,185 | $4.07 | $17.0K | Form 4 |
| Mirza Nadeem Q. | Chief Medical Officer | May 1, 2024 | AWARD | 26,920 | $5.25 | $141.3K | Form 4 |
| Mirza Nadeem Q. | Chief Medical Officer | May 1, 2024 | AWARD | 6,730 | — | — | Form 4 |
| Mirza Nadeem Q. | Chief Medical Officer | May 1, 2024 | DISPOSED | 2,250 | $7.80 | $17.6K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 28, 2024 | AWARD | 3,365 | — | — | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 28, 2024 | AWARD | 13,460 | $6.69 | $90.0K | Form 4 |
| Gilad Oren | director, officer: President, CEO | Mar 28, 2024 | AWARD | 6,725 | — | — | Form 4 |
| Gilad Oren | director, officer: President, CEO | Mar 28, 2024 | AWARD | 26,900 | $6.69 | $180.0K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | BUY | 1,010 | $7.29 | $7.4K | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | BUY | 505 | — | — | Form 4 |
| Hamill John P. | SrVP/CFO/Prin Fin & Acct Ofcr | Mar 13, 2024 | BUY | 505 | — | — | Form 4 |
| Seizinger Bernd R. | director | Mar 13, 2024 | BUY | 6,860 | $7.29 | $50.0K | Form 4 |
| Seizinger Bernd R. | director | Mar 13, 2024 | BUY | 3,430 | — | — | Form 4 |
| Seizinger Bernd R. | director | Mar 13, 2024 | BUY | 3,430 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Mar 13, 2024 | BUY | 6,860 | $7.29 | $50.0K | Form 4 |
| HENNEMAN JOHN B III | director | Mar 13, 2024 | BUY | 3,430 | — | — | Form 4 |
| HENNEMAN JOHN B III | director | Mar 13, 2024 | BUY | 3,430 | — | — | Form 4 |
| Gilad Oren | director, officer: President, CEO | Mar 13, 2024 | BUY | 2,000 | $7.29 | $14.6K | Form 4 |
| Gilad Oren | director, officer: President, CEO | Mar 13, 2024 | BUY | 1,000 | — | — | Form 4 |
| Gilad Oren | director, officer: President, CEO | Mar 13, 2024 | BUY | 1,000 | — | — | Form 4 |
| Pamukcu Rifat | director | Aug 23, 2022 | CONVERSION | 49,280 | — | — | Form 4 |
| Pamukcu Rifat | director | Aug 23, 2022 | CONVERSION | 271,870 | — | — | Form 4 |
| Pamukcu Rifat | director | Aug 23, 2023 | AWARD | 500 | — | — | Form 4 |